# Software Safety Case Summary

## Purpose
Summarize software safety claims, supporting evidence, and unresolved gaps for readiness review.

## Scope
Covers runtime safety stages, sensory exposure controls, full-dive emergency exit, reality anchor, decompression, watchdog, HIL fault handling, cybersecurity controls, and traceability to hazards.

## Current status
- Safety case structure: present.
- Evidence grade: draft and simulation/HIL-scaffold only.
- Human-use readiness: not established.

## Required evidence
- Claim-argument-evidence safety case linked to each high-severity hazard.
- Signed residual-risk acceptance and benefit-risk rationale.
- HIL scenario evidence for emergency exit, phantom disconnect, latency overrun, overload, and recovery.
- Long-run determinism and no-allocation evidence.

## Available evidence
- Safety and runtime tests cover watchdog, safety state machine, sensory exposure, runtime safety stage, full-dive bridge intervention, and emergency exit paths.
- Traceability matrix links requirements to hazards and tests.
- HIL evidence summary identifies current scaffold coverage.

## Missing evidence
- Independent safety review sign-off.
- Non-simulated HIL session reports.
- Residual-risk decisions with named accountable approvers.
- Formal clinical stopping rules and operator training evidence.

## Linked artifacts
- `docs/FULL_DIVE_HAZARD_ANALYSIS.md`
- `docs/RISK_CONTROL_MEASURES.md`
- `docs/RESIDUAL_RISK_EVALUATION.md`
- `docs/EMERGENCY_EXIT_SAFETY_CASE.md`
- `docs/REALITY_ANCHOR_SAFETY_CASE.md`
- `docs/STIMULUS_SAFETY_CASE.md`

## Linked tests
- `dnxr_safety_unit_test`
- `dnxr_safety_state_machine_test`
- `dnxr_watchdog_failure_test`
- `dnxr_runtime_safety_stage_test`
- `dnxr_hil_emergency_stop_test`

## Reviewer / status
- Document owner: QMS software lead.
- Review state: Structured draft requiring independent clinical, regulatory, cybersecurity, and safety review before any submission.
- Current readiness conclusion: not ClinicalTestReady; this package supports gap closure and expert review only.

## Next actions
1. Replace simulated/HIL scaffold evidence with protocol-bound bench and HIL run records.
2. Complete independent risk review and resolve open residual-risk decisions.
3. Execute the clinical-readiness validation lane with long-run tests enabled.
4. Attach signed reviewer approvals, protocol identifiers, and dated evidence records.
